| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762189 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | CA2358479C 4-substituted-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine |
| 07/13/2004 | CA2313106C Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents |
| 07/13/2004 | CA2272690C Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives |
| 07/13/2004 | CA2255333C Quinolinone derivative, method for preparing the same, and anti-allergic agent |
| 07/13/2004 | CA2244771C Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same, and use thereof |
| 07/09/2004 | CA2676216A1 Aripiprazole |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056992A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same |
| 07/08/2004 | WO2004056815A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 07/08/2004 | WO2004056812A1 4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents |
| 07/08/2004 | WO2004056808A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056807A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056806A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases |
| 07/08/2004 | WO2004056805A1 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056804A2 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 07/08/2004 | WO2004056803A1 Process for the preparation of sulphinyl derivatives by oxidation of the corresponding sulfides |
| 07/08/2004 | WO2004056802A1 Complexes of e-2-methoxy-n-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide, their method of production, and use |
| 07/08/2004 | WO2004056801A1 Quinazoline derivatives |
| 07/08/2004 | WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056798A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/08/2004 | WO2004056786A2 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments |
| 07/08/2004 | WO2004056782A1 Pyrazole compounds |
| 07/08/2004 | WO2004056780A2 Tetrahydroquinoline derivatives |
| 07/08/2004 | WO2004056779A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 07/08/2004 | WO2004056775A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | WO2004056773A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists |
| 07/08/2004 | WO2004056770A2 Piperidine derivatives useful as ccr5 antagonists |
| 07/08/2004 | WO2004056766A1 Inhibitors of tace |
| 07/08/2004 | WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders |
| 07/08/2004 | WO2004056366A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/08/2004 | WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | WO2004048352A3 2-cyanopyrrolidines and their analogues as dpp-iv inhibitors |
| 07/08/2004 | WO2004041755A3 Quinazolinone compounds as calcilytics |
| 07/08/2004 | WO2004037791B1 Inhibitors of glycogen synthase kinase 3 |
| 07/08/2004 | WO2004037171A3 Mitotic kinesin inhibitors |
| 07/08/2004 | WO2004029024A3 Radiolabeled neurokinin-1 receptor antagonists |
| 07/08/2004 | WO2004024682A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity. |
| 07/08/2004 | WO2004012663A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2003106628A3 Benzodiazepine inhibitors of mitochondial f¿1<f¿0? atp hydrolase and methods of inhibiting f¿1?f¿0? atp hydrolase |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040132993 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132804 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 07/08/2004 | US20040132801 Therapeutic proline derivatives |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132799 Aminoalkoxyindoles and methods of use |
| 07/08/2004 | US20040132786 Differential tumor cytotoxicity compounds and compositions |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132779 benzoyl- or pyridinoyl-amimo phenyl- or pyridinylmethylaminocarbonyl compounds, e.g., 4-[(2-acetylamino-2-phenyl-acetylamino)-methyl]-2-methylphenyl-4'-trifluoromethylbiphenyl-2-carboxamide; antiobesity and antiatherosclerosis agents |
| 07/08/2004 | US20040132774 Especially (2R)-N-(1-(6-aminopyridin-2-ylmethyl)1-methyl-piperdin-4-yl)-2-((1R)-3,3, -difluorocyclopentyl)-2-hydroxy-2-phenylacetamide iodide; treating asthma, chronic obstructive pulmonary disorder and allergic or infectious rhinitis |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132756 incorporating tartaric acid in a solid preparation having a high content of a quinolone compound, particularly sitafloxacin; reduced in fluctuations of oral absorption |
| 07/08/2004 | US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia. |
| 07/08/2004 | US20040132747 Novel heteroaryl derivatives and their use as medicaments |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/08/2004 | US20040132738 e.g., 3-[(5-benzyloxypyridin-2-yl)methylidene]-6-phenylmethylidene piperazine-2,5-dione; treating an angiogenesis-related disease. |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132733 Novel quinoxalinone derivatives as bradykinin B1 antagonists |
| 07/08/2004 | US20040132732 Quinazolinones and derivatives thereof as factor Xa inhibitors |
| 07/08/2004 | US20040132730 Inhibitors of TGFbeta |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132727 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/08/2004 | US20040132724 e.g., cis-1-Acetyl-6-ethyl-N-(4-ethylphenyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinamine; atopic dermatitis, urticaria, various allergies bullous pemphigoid, industrial sensitization, chronic transplant rejection and COPD |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132721 Treatment of airway disorders |
| 07/08/2004 | US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 07/08/2004 | US20040132716 CGRP antagonists |
| 07/08/2004 | US20040132711 Treatment of Human Immunodeficiency Virus, organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis. |
| 07/08/2004 | US20040132710 Lactams as tachkinin antagonists |
| 07/08/2004 | DE10257358A1 Substituierte Pyrrole Substituted pyrroles |
| 07/08/2004 | CA2511321A1 Pyrazole-derivatives as factor xa inhibitors |
| 07/08/2004 | CA2511182A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/08/2004 | CA2510850A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 07/08/2004 | CA2510849A1 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
| 07/08/2004 | CA2510848A1 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions |
| 07/08/2004 | CA2510815A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | CA2510069A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | CA2510027A1 Piperidine derivatives useful as ccr5 antagonists |
| 07/08/2004 | CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | CA2509403A1 Pyrazole compounds |